menu
    • menu

    Company profile for Biosion

    NEW Drugs in Dev: 3
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Biosion is a leading “In Global For Global” clinical stage biotechnology company developing innovative biologics to address resistant, relapsed and residual disease for patients worldwide. Established in 2017, Biosion has assembled a world-class team with extensive experience in global biologics development and built an oncology and auto-immune focused pipeline of innovative biologics through its internally-derived proprie...
    Biosion is a leading “In Global For Global” clinical stage biotechnology company developing innovative biologics to address resistant, relapsed and residual disease for patients worldwide. Established in 2017, Biosion has assembled a world-class team with extensive experience in global biologics development and built an oncology and auto-immune focused pipeline of innovative biologics through its internally-derived proprietary technologies, including the H3 hybridoma platform, SynAbTM synergistic antibody platform, SynTracerTM HT-endocytosis screening, and FlexibodyTM bispecific platforms.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BiosionChina Flag
    Country
    Country
    China
    Address
    Address
    3-1 Zhongdan Unit South Longshan Rd Jiangbei New District Nanjing, Jiangsu
    Telephone
    Telephone
    (86) 025-5829-1977
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biosion.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/biosion
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biosion Launches Phase 1 Trial of BSI-082 for Advance Solid Tumor
    Biosion Launches Phase 1 Trial of BSI-082 for Advance Solid Tumor

    03 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biosion-announces-first-patient-dosed-in-investigator-initiated-phase-1-trial-of-bsi-082-a-next-generation-anti-sirp-monoclonal-antibody-for-advanced-solid-tumors-302677434.html

    PR NEWSWIRE
    03 Feb 2026
    Share Share
    Biosion Names Kedan Lin, Ph.D., Chief Development Officer
    Biosion Names Kedan Lin, Ph.D., Chief Development Officer

    19 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biosion-inc-appoints-kedan-lin-phd-as-chief-development-officer-and-president-of-biosion-us-302380135.html

    PR NEWSWIRE
    19 Feb 2025
    Share Share
    Aclaris Therapeutics Announces Global License Agreement with Biosion
    Aclaris Therapeutics Announces Global License Agreement with Biosion

    18 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/18/2982759/37216/en/Aclaris-Therapeutics-Announces-Exclusive-Global-License-Agreement-with-Biosion-Inc-adding-Potential-Best-in-Class-Biologics-Assets-to-Pipeline.html

    GLOBENEWSWIRE
    18 Nov 2024
    Share Share
    Biosion Announces Global License with Aclaris for Immunology Assets
    Biosion Announces Global License with Aclaris for Immunology Assets

    18 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biosion-announces-exclusive-global-license-agreement-with-aclaris-therapeutics-on-two-potential-first-in-class-and-best-in-class-immunology-assets-302308547.html

    PR NEWSWIRE
    18 Nov 2024
    Share Share
    Biosion to Present Three Posters at the 2024 AACR Meeting
    Biosion to Present Three Posters at the 2024 AACR Meeting

    21 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biosion-to-present-three-posters-at-the-2024-aacr-meeting-302095772.html

    PR NEWSWIRE
    21 Mar 2024
    Share Share
    OBI Pharma Announces FDA Clearance of IND Application for a Phase 1/2 of OBI-992
    OBI Pharma Announces FDA Clearance of IND Application for a Phase 1/2 of OBI-992

    08 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biosions-partner-obi-pharma-announces-fda-clearance-of-ind-application-for-a-phase-12-study-of-obi-992-trop2-adc-302028402.html

    PR NEWSWIRE
    08 Jan 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search